Bristol-Myers Squibb (BMY) Misses Q1 EPS by 7c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $48.30 --0%
EPS Growth %: -21.5%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -21.5%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.74, $0.07 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $11.1 billion versus the consensus estimate of $11.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.48.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Provident Financial Services (PFS) Tops Q1 EPS by 3c
- Elevance Health (ELV) hikes 2024 earnings outlook, shares climb
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
